# Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris

> **NCT01974323** · PHASE3 · COMPLETED · sponsor: **Almirall, S.A.** · enrollment: 2238 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** Dapsone Gel
- **DRUG:** Dapsone Gel Vehicle

## Key facts

- **NCT ID:** NCT01974323
- **Lead sponsor:** Almirall, S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 2238 (ACTUAL)
- **Last updated:** 2018-10-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01974323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01974323, "Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01974323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*